The World Health Organization (WHO) has escalated the mpox outbreak in parts of Africa to a public health emergency of international concern, citing the alarming spread and high fatality rates associated with the disease. Formerly known as monkeypox, mpox has resulted in at least 450 deaths during an initial outbreak in the Democratic Republic of Congo (DRC) and has since spread to other regions including Burundi, the Central African Republic, Kenya, and Rwanda.
The declaration follows a concerning surge in cases linked to a more dangerous variant of the disease, Clade 1b, which has emerged from the previously known Clade 1. This variant has shown a significantly higher mortality rate, with up to 10% of infected individuals succumbing to the illness in past outbreaks.
WHO Chief Tedros Adhanom Ghebreyesus emphasized the urgency of a coordinated international response to prevent further spread both within Africa and globally. Mpox spreads through close contact, including skin-to-skin contact and respiratory droplets, and presents with symptoms such as flu-like illness and skin lesions. The disease’s severity and transmission dynamics are raising concerns among scientists and public health officials.
Since the start of the year, over 13,700 cases have been reported in the DRC alone. The outbreak represents a critical test for international health systems, as the global community faces the challenge of addressing this growing health crisis.
The current situation mirrors the 2022 outbreak of the milder Clade 2 strain, which led to significant global spread and was eventually managed through targeted vaccination efforts. The WHO’s latest declaration aims to catalyze accelerated research, funding, and public health measures to tackle the new strain of mpox.
Experts, including Dr. Josie Golding from the Wellcome Trust and Dr. Boghuma Titanji from Emory University, have welcomed the WHO’s move as a crucial step in addressing the crisis. However, they also note the need for a proactive and aggressive containment strategy to manage the outbreak effectively.
Jean Kaseya, head of the Africa Centres for Disease Control and Prevention, echoed the urgency, stressing that immediate action is necessary to contain and eliminate the threat posed by this dangerous new strain. The declaration is expected to spur enhanced global coordination and resource mobilization to combat the outbreak and mitigate its impact on affected populations.
The World Health Organization (WHO) has escalated the mpox outbreak in parts of Africa to a public health emergency of international concern, citing the alarming spread and high fatality rates associated with the disease. Formerly known as monkeypox, mpox has resulted in at least 450 deaths during an initial outbreak in the Democratic Republic of Congo (DRC) and has since spread to other regions including Burundi, the Central African Republic, Kenya, and Rwanda.
The declaration follows a concerning surge in cases linked to a more dangerous variant of the disease, Clade 1b, which has emerged from the previously known Clade 1. This variant has shown a significantly higher mortality rate, with up to 10% of infected individuals succumbing to the illness in past outbreaks.
WHO Chief Tedros Adhanom Ghebreyesus emphasized the urgency of a coordinated international response to prevent further spread both within Africa and globally. Mpox spreads through close contact, including skin-to-skin contact and respiratory droplets, and presents with symptoms such as flu-like illness and skin lesions. The disease’s severity and transmission dynamics are raising concerns among scientists and public health officials.
Since the start of the year, over 13,700 cases have been reported in the DRC alone. The outbreak represents a critical test for international health systems, as the global community faces the challenge of addressing this growing health crisis.
The current situation mirrors the 2022 outbreak of the milder Clade 2 strain, which led to significant global spread and was eventually managed through targeted vaccination efforts. The WHO’s latest declaration aims to catalyze accelerated research, funding, and public health measures to tackle the new strain of mpox.
Experts, including Dr. Josie Golding from the Wellcome Trust and Dr. Boghuma Titanji from Emory University, have welcomed the WHO’s move as a crucial step in addressing the crisis. However, they also note the need for a proactive and aggressive containment strategy to manage the outbreak effectively.
Jean Kaseya, head of the Africa Centres for Disease Control and Prevention, echoed the urgency, stressing that immediate action is necessary to contain and eliminate the threat posed by this dangerous new strain. The declaration is expected to spur enhanced global coordination and resource mobilization to combat the outbreak and mitigate its impact on affected populations.
